```json { "action": "final", "content": "## Temporal Pattern Analysis: Adverse Events Over Time\n\nThe dataset tracks adverse events from **July 2012 through November 2014** using the `AEDTC` column. The time series reveals several notable patterns:\n\n### Key Findings\n\n**Major Spike (Early 2013)**\n- The most dramatic increase occurs from **December 2012 (36 events) to February 2013 (75 events)**, more than doubling in two months\n- This peaks at **87 events in March 2013**, the highest single month in the entire dataset\n- The elevated activity continues through mid-2013, with May-June 2013 averaging ~80 events/month\n\n**Sustained Decline (Late 2013 - 2014)**\n- After the March 2013 peak, there's a gradual decline through the remainder of 2013\n- December 2013 shows a notable dip to **37 events** (down from 78 in November)\n- 2014 shows consistently lower activity, averaging 30-50 events/month in Q1-Q2\n\n**Sharp Drop-off (Mid-2014)**\n- The most striking break occurs in **August 2014**, plummeting to just **8 events**\n- September-November 2014 remain extremely low (**2-4 events/month**), suggesting either:\n - Trial completion/wind-down phase\n - Data collection lag (events not yet recorded)\n - Significant protocol change or patient attrition\n\n**Ramp-up Period (Late 2012)**\n- The trial begins with minimal activity: just **1 event in July 2012**\n- Rapid enrollment is evident as events jump to 32 by September 2012\n\n### Clinical Interpretation\n\nThe March 2013 spike and subsequent elevated period likely reflects peak trial enrollment and patient exposure. The dramatic 2014 decline, particularly the August cliff, strongly suggests the trial entered its closeout phase, with most patients completing treatment and follow-up by mid-2014.", "charts": [ { "kind": "line", "x": "month", "series": ["event_count"], "title": "Adverse Events Over Time (Monthly)" } ] } ```